The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...

Researchers from University of Arizona present a new therapeutic target to shield nerve cells from the damage of ALS.

This eBook explores how researchers can move beyond correlation and towards mechanism in microbiome research—from preserving physiologically relevant microbial communities to directly measuring ...

Less than a month after its stock roller-coastered on safety signals associated with its late-stage ulcerative colitis (UC) ...

As instruments grow faster, leaders say clinical impact will depend on trust, standards, data, and assays built for real ...

Synthetic organizers provide a way to control formation of kidney organoids as more reliable models for studying disease and ...

The work with Nvidia also focuses on the agentic guardrails required for the responsible and reliable deployment of AI in lab ...

Pierre-Alain Ruffieux, Cytiva’s group executive, bioprocess, discusses completion of the doubling of the company’s liquid ...

To date, the company has raised over $34 million from investors and operates a 15-person team at facilities at Johns Hopkins Medical Campus.

Basecamp Research’s antibiotic design and vaccine prediction AI models are now available through Anthropic’s Claude Science.

Researchers say newly identified cholesterol control pathway is completely separate from anything targeted by existing drugs.

Preclinical study showed iRECs Integrated into host vascular network and revascularized the ischemic eye, rescuing the tissue.